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Overexpression of IRS2 in isolated pancreatic islets causes
proliferation and protects human beta-cells from
hyperglycemia-induced apoptosis
Abstract
Studies in vivo indicate that IRS2 plays an important role in maintaining functional beta-cell mass. To
investigate if IRS2 autonomously affects beta-cells, we have studied proliferation, apoptosis, and
beta-cell function in isolated rat and human islets after overexpression of IRS2 or IRS1. We found that
beta-cell proliferation was significantly increased in rat islets overexpressing IRS2 while IRS1 was less
effective. Moreover, proliferation of a beta-cell line, INS-1, was decreased after repression of Irs2
expression using RNA oligonucleotides. Overexpression of IRS2 in human islets significantly decreased
apoptosis of beta-cells, induced by 33.3 mM D-glucose. However, IRS2 did not protect cultured rat
islets against apoptosis in the presence of 0.5 mM palmitic acid. Overexpression of IRS2 in isolated rat
islets significantly increased basal and D-glucose-stimulated insulin secretion as determined in
perifusion experiments. Therefore, IRS2 is sufficient to induce proliferation in rat islets and to protect
human beta-cells from D-glucose-induced apoptosis. In addition, IRS2 can improve beta-cell function.
Our results indicate that IRS2 acts autonomously in beta-cells in maintenance and expansion of
functional beta-cell mass in vivo.
S. Mohanty et al. Ectopic expression of IRS2 in isolated islets 
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Abstract 
Aims/hypothesis. Studies in vivo indicate that IRS2 plays an important role in maintaining 
functional β-cell mass. To investigate if IRS2 autonomously affects β-cells ex vivo, we have 
studied proliferation, apoptosis and β-cell function in isolated rat and human islets and in 
INS-1 cells after overexpression or repression of IRS2. Methods. Suspension cultures and 
monolayers of isolated islets were transfected with adenoviral vectors for ectopic expression 
of transgenes. IRS2 was downregulated in INS-1 cells with antisense RNA oligonucleotides. 
Proliferating β-cells were detected by anti-Ki-67/insulin staining while proliferation of INS-1 
cells was assessed by measuring [3H]thymidine incorporation. TUNEL or Annexin-V staining 
was applied to detect apoptosis. Insulin secretion was assessed in perifusion experiments. 
Results. β-cell proliferation was significantly increased (8 to 9-fold; p<0.05) in rat islets 
overexpressing IRS2. The increase in proliferation was found to be specific for IRS2 because 
IRS1 and Shc were less effective. Proliferation of INS-1 cells was decreased after repression 
of Irs2. Overexpression of IRS2 in human islets significantly decreased apoptosis of β-cells 
induced by 33.3 mM D-glucose. However, IRS2 did not protect cultured rat islets in the 
presence of 0.5 mM palmitic acid against apoptosis. Overexpressing IRS2 resulted in 
significantly increased basal and D-glucose-stimulated insulin secretion as determined by 
perifusion experiments. Conclusions. IRS2 is sufficient to induce proliferation in rat islets and 
to protect human β-cells from D-glucose-induced apoptosis. Our results indicate that IRS2 
acts autonomously in β-cells and may play an important role in maintenance and expansion of 
functional β-cell mass in vivo. 
 
Keywords: Insulin receptor substrate, diabetes, β-cell, INS-1, proliferation, apoptosis. 
 
Abbreviations: PKB protein kinase B; FLIP Fas-associated death domain (FADD)-like 
interleukin-1β-converting enzyme (FLICE inhibitory protein); cAMP cyclic adenosine 
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monophosphate; GFP green fluorescence protein; PBS phosphate buffered saline; TBST tris 
buffered saline tween 20; MOI multiplicity of infection; pfu plaque forming units; TUNEL 
terminal deoxynucleotidyltransferase (TdT)-mediated dUTP nick end labeling; FFA free fatty 
acids. 
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Introduction 
 
Studies in animal models and observations in human pancreatic tissue indicate that β-cell 
mass is not static but dynamic and can adapt to changes in insulin demand [1,2]. Maintenance 
of functional β-cell mass is important in light of the pathogenesis of type 2 diabetes where 
increasing peripheral insulin resistance leads to an increasing demand for insulin, which is 
compensated in the early stages by a corresponding expansion in β-cell mass [3]. As the β-
cells eventually fail to compensate and even recess in the face of chronic hyperglycaemia, 
diabetes ensues. Therefore, it is important to identify factors or pathways which prompt 
proliferation of β−cells or decrease apoptosis in order to maintain an adequate capacity for 
insulin secretion. 
Increases in β-cell mass may occur via proliferation, cellular growth and/or reduced cell 
death. Although β-cell number increases mainly by neogenesis during embryonic and foetal 
life, a small fraction of adult β-cells is able to undergo cell division and can be recruited to re-
enter the cell cycle [4]. Changes in β-cell size (hypertrophy) have also been reported [5,6]. On 
the other hand, a decrease in functional β-cell mass, as observed in type 2 diabetes, is believed 
to depend on apoptosis and to be induced by a combination of humoral and autocrine factors. 
It has been shown that both chronically elevated concentrations of D-glucose as well as 
increased concentrations of saturated free fatty acids (FFA) like palmitic acid induce β-cell 
apoptosis [7,8,9,10]. Both of these factors are likely to play a role in the transition to the 
diabetic state in insulin resistant individuals. 
Numerous studies have indicated that signal transduction through the insulin/IGF-
receptor pathway is involved in the regulation of β-cell mass and function (for review see 
[11]). Insulin and insulin-like growth factor-1 (IGF-1) are growth factors for β-cells and their 
receptors use IRS proteins for signal transmission [12]. The role of these important signalling 
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components for β-cell growth and function has been studied in knock out mice as well as in β-
cell-derived cell lines (for review see [13]). Mice deficient for Irs1 display insulin resistance 
in muscle and fat but never develop diabetes because of compensatory expansion of β-cell 
mass [14,15]. On the other hand, Irs2 deficient mice develop diabetes at 3-6 weeks [16] or 10 
weeks [17] of age because of their inability to compensate for insulin resistance in the liver. 
Such mice show loss of β-cell mass and a reduction of insulin content indicating, that Irs2 but 
not Irs1 is required for maintenance of β-cell mass and function. Loss of Irs3 or Irs4 did not 
significantly affect glucose homeostasis [18,19]. Recently, it was found that β-cell-specific 
expression of IRS2 increases β-cell survival and prevents diabetes in Irs2-/- mice [20]. 
Since β-cell-specific Irs2 knockout mice are not yet available, secondary effects on the 
regulation of β-cell mass can not be ruled out. In addition, it is not clear at this point if IRS2 is 
also sufficient to induce proliferation in β-cells ex vivo. To answer these questions, we have 
used monolayers of cultured isolated islets [21] to study β-cell proliferation and apoptosis. 
We have determined the number of proliferating β-cells in isolated rat islets after 
overexpression of IRS2 or GFP under the control of the cytomegalovirus (CMV) promoter. 
We also determined the proliferation rate of a β-cell line (INS-1) after anti-sense RNA-
mediated downregulation of IRS2. In addition we asked, whether overexpression of IRS2 can 
protect β-cells from high D-glucose- and free fatty acid-induced apoptosis. Finally, we 
determined β-cell functionality by measuring insulin secretion in perifusion experiments with 
islets that overexpressed IRS2. 
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Materials and Methods 
 
Generation of recombinant adenoviral vectors. Full length cDNAs encoding mouse IRS2, 
human IRS1 or human Shc were cloned into a transfer vector that provides a C-terminal Myc 
tag. Cre recombination into a suited adenoviral vector, based on subtype V that lacks portion 
of the E1 and E3 region were performed in prokaryotic cells (Trüb et al, manuscript in 
preparation). Adenoviral particles were obtained after transfection into a helper cell line 
(human embryonic kidney-293, HEK-293). Overexpression of the respective transgenes was 
confirmed by Western blotting after transfection of a β-cell-derived cell line (INS-1). Viral 
titers (plaque forming units/ml, pfu/ml) were determined for each preparation in a plaque 
assay. Islets were transfected at a multiplicity of infection (MOI) of 1000 (assuming 103 β-
cells per islet). Expression levels of the different transgenes were compared in lysates from 
Chinese Hamster Ovary cells expressing the insulin receptor (CHO-IR) after transfection with 
viral preparations at the same MOI. Similar signal intensities were obtained for IRS1-Myc, 
IRS2-Myc and Shc-Myc in such experiments indicating that all three vectors yield 
comparable expression levels (not shown). 
 
Rat islets: isolation, adenoviral gene transfer and culture with free fatty acids. Islets were 
isolated from adult male Sprague-Dawley rats (200-250 g) according to Gotoh et al [22]. 
Briefly, the common pancreatic duct was ligated where it enters the duodenum and injected 
with 10 ml cold Hanks’ Balanced Salt Solution (HBSS) containing 0.17 g of Liberase 
(Boehringer Mannheim, Germany), 0.1 mg/ml of DNAse I (Boehringer Mannheim, Germany) 
and 0.02 M HEPES, pH 7.4. Pancreata were removed and digested in a shaking water bath at 
37°C for 20 min. The digestion was stopped with HBSS containing 10 % foetal calf serum 
(v/v, FCS, Invitrogen, USA) instead of Liberase followed by filtration through cheese cloth. 
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The islets were separated from the digested pancreas by centrifugation (20 min at 1200 rpm) 
through a discontinuous Histopaque 1077 (Sigma, USA) gradient, washed with RPMI-1640 
medium (Invitrogen, USA), and cultured in 2 ml of RPMI-1640 medium (11.1 mM D-
glucose) containing 100 U/ml penicillin, 100 µg/ml streptomycin, 40 µg/ml gentamicin, and 
10% (v/v) FCS on 35 mm plates coated with extra-cellular matrix (ECM) derived from bovine 
corneal endothelial cells (Novamed, Israel) at 37 °C, 5 % CO2. 
After 24 hours of incubation, when most islets began to flatten, the medium was changed 
to fresh RPMI-1640 medium (11.1 mM D-glucose) and exposed for 24 hours to 2 x 106 pfu of 
adenovirus. Infectivity was monitored using adenovirus encoding GFP. For incubation with 
FFA, medium was changed the next day to RPMI-1640 (11.1 mM D-glucose) with or without 
0.5 mM palmitic acid complexed to 0.5 % BSA for 72 hours. Palmitic acid was dissolved 
overnight at 10 mM in RPMI-1640 medium containing 11 % fatty acid–free BSA (Sigma, 
USA) at 37 °C in a shaking water bath under N2 atmosphere. Subsequently, the pH was 
adjusted to 7.4 with 1 N NaOH and the solution was filtered through a 0.2 micron sterile filter 
and stored at –20 °C. Before use, the effective free fatty acid concentrations were checked 
with a commercially available kit (Wako, Germany). 
 
Human islets: isolation, adenoviral gene transfer and culture with D-glucose. Human islets 
were isolated from pancreata of five heart-beating cadaver organ donors (aged 30-50 years) at 
the Division of Endocrinology and Diabetes, University Hospital Zurich, according to 
Linetsky et al [23]. None of the donors had a history of diabetes or metabolic disorders. The 
islet purity was >90 % as judged by dithizone staining. Each experiment was set up in 
triplicate. After isolation, hand picked islets were cultured on ECM dishes [21] in 5.5 mM 
CMRL-1066 medium (Invitrogen, USA) containing 100 U/ml penicillin, 100 µg/ml 
streptomycin, and 10 % (v/v) FCS at 37 °C, 5 % CO2. After 24 hours, when the islets had 
flattened, the culture medium was changed and islets were infected with the respective 
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adenoviral constructs. After 18 hours, the medium containing adenovirus was removed and 
replaced with CMRL-1066 medium containing 5.5 or 33.3 mM glucose for an additional 72 
hours.  
 
Quantification of β-cell proliferation. Islets on ECM plates were washed with phosphate 
buffered saline (PBS) and fixed with 4 % paraformaldehyde for 30 min at room temperature, 
followed by permeabilization with 0.5 % Triton X-100 in PBS for 4 min at room temperature. 
Fixed islets were incubated in blocking solution (Histostain Plus Kit, Zymed, USA) for 30 
min at room temperature and β-cell proliferation was determined using an antibody against 
Ki-67 nuclear antigen (expressed during G1, G2, M and S phases of the cell cycle, [24]). 
Mouse monoclonal anti-Ki-67 antibody (Zymed, USA) was added to the islets at a dilution of 
1:10 in PBS for 30 min at 37 °C in a moist chamber. For human islets, a prediluted 
monoclonal mouse anti-human Ki-67 antibody (Zymed, USA) was used. Subsequently, the 
islets were washed three times with PBS and signals were detected using the Histostain-Plus 
Kit (Zymed, USA). Co-staining for insulin was done using a guinea pig anti-insulin antibody 
diluted 1:50 (Dako, USA) for 30 min at 37 °C, followed by a 10 min incubation with a 1:10 
dilution of fluorescein-conjugated rabbit anti–guinea pig secondary antibody (Dako, USA). β-
cells positive for Ki-67 were counted and expressed as number of proliferating β-cells per 
total number of β-cells. Scion Image software (Scion Corporation, USA) was used to assess 
islet size and care was taken to score islets of similar sizes. 
 
Quantification of β-cell apoptosis. β-cell apoptosis was determined using the terminal 
deoxynucleotidyltransferase (TdT)-mediated dUTP nick end labeling (TUNEL) assay [25]. 
Briefly, after the islets were fixed and washed, cell death was detected by enzymatic in situ 
labeling of DNA strand breaks using the In Situ Cell Death Detection Kit AP (Boehringer 
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Mannheim, Germany). Detection was by staining with nitro blue tetrazolium/5-bromo-4-
chloro-3-indoyl phosphate (Sigma, USA) as a substrate. Subsequently, the islets were co-
stained with anti-insulin antibody as described above. The apoptotic cells were counted and 
expressed as number of apoptotic β-cells per total number of β-cells. To exclude the 
possibility of counting necrosis rather than apoptosis, we used the Annexin-V-FLUOS 
Staining Kit (Roche, Switzerland) which contains annexin-V-fluorescein and propidium 
iodide for differentiating apoptotic versus necrotic cells. 
 
Analysis of IRS2 expression. Western blotting: After isolation, rat islets were cultured in 
suspension dishes in RPMI-1640 medium containing 11.1 mM D-glucose. They were infected 
with recombinant adenoviral constructs encoding GFP or IRS2 for different periods of time. 
Islets were lysed in freshly prepared ice-cold lysis buffer consisting of 50 mM HEPES (pH 
7.5), 140 mM NaCl, 0.5 % (v/v) Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 3 μg/ml 
leupeptin, 3 μg/ml apoprotinin, 10 mM sodium fluoride, 1 mM disodium pyrophosphate, and 
1 mM sodium orthovanadate. Protein concentrations in lysates were determined by the 
Bicinchoninic Acid Assay (Pierce, USA). Equal amounts of protein were run on 7 % SDS 
polyacrylamide gels and transferred onto nitrocellulose membranes. Non-specific binding of 
antibodies to membranes was blocked using 2 % non-fat milk in TBST (10 mM Tris-HCl, pH 
7.4, 150 mM NaCl, 0.05 % (v/v) Tween 20). Incubation with anti-IRS2 antibody (Upstate 
biotechnologies, USA, cat. #06-506) was for 1 h at room temperature followed by incubation 
with horseradish peroxidase-linked anti-rabbit secondary antibody (Santa Cruz 
Biotechnology, USA) for 1 h at room temperature. A monoclonal antibody against actin 
(Chemicon, USA) was used to control for differences in loading. Immunoreactive proteins 
were visualised by the Lumi-Light Western Blotting Substrate (Roche, Germany). 
Detection in fixed islets: Flattened islets were washed with PBS and fixed with 4 % 
paraformaldehyde for 30 min at room temperature, followed by permeabilization with 0.5 % 
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Triton X-100 in PBS for 4 min at room temperature. Non-specific binding was blocked by 
incubation with blocking solution from Histostain-Plus Kit (Zymed, USA) for 10 min at room 
temperature. IRS2 was detected with a polyclonal anti-IRS2 antibody (Upstate biotechnology, 
USA) for 30 minutes at 37°C followed by 30 minutes of incubation with Cy2 conjugated 
donkey anti-rabbit secondary antibody (Jackson Immunoresearch, USA). 
Immunofluorescence was detected with a Zeiss fluorescence microscope (Axiolab).  
 
Cell culture. INS-1 cells (gift from C. Wolheim, University of Geneva, Switzerland) were 
maintained in RPMI-1640 medium containing 11 mM D-glucose supplemented with 10 % 
(v/v) heat inactivated FCS, 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, 
50 μg/ml gentamycin, 1 mM sodium pyruvate, 10 mM HEPES (pH 7.3) and 50 μM β-
mercaptoethanol, at 37° C, under 5 % CO2 in a humidified atmosphere. CHO-IR cells 
(obtained from J. E. Pessin, University of Iowa, USA) were maintained in F12 medium 
(Invitrogen, USA) containing 10 % (v/v) FCS, 100 U/ml penicillin, 100 mg/ml streptomycin. 
HEK293 cells were cultured in DMEM-H medium (Invitrogen, USA) containing 10 % FCS, 
100 U/ml penicillin, 100 mg/ml streptomycin. 
 
Downregulation of IRS2 expression using antisense RNA. 21 nt RNAs corresponding to rat 
Irs2 were chemically synthesised (Microsynth GmbH, Switzerland). Sequences used are 5’-
UCC CUC CCU GCG UCC UCU CdTT (sense) and 5’-GAG AGG ACG CAG GGA GGG 
AdTT (antisense). We originally planned to use dsRNA [26] to repress Irs2. However, 
antisense RNA proved to be most effective in suppressing IRS2 expression and therefore this 
oligonucleotide was used in subsequent experiments. Transfection of RNA oligonucleotides 
was accomplished using Oligofectamine (Invitrogen AG, Switzerland). Briefly, INS-1 cells 
were cultured in RPMI-1640 medium containing 11.1 mM D-glucose and 10 % (v/v) FCS on 
24 well plates to 70 % confluence. They were serum deprived by changing the medium to 
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RPMI-1640 containing 11.1 mM D-glucose without FCS and thereafter 0.8 μg of RNA 
oligonucleotides complexed to Oligofectamine were added according to the manufacturer's 
instructions. After 4 hours, FCS was added to the medium to 10 % (v/v) final concentration 
and the transfected cells were incubated at 37 °C in a CO2 incubator. Cell extracts were 
prepared and assayed for IRS2 expression at the 5th day post transfection. 
 
Determination of [3H]thymidine incorporation. Thymidine incorporation was used to assess 
β-cell proliferation in INS-1 cells. Briefly, five days after transfection of cells with RNA 
oligonucleotides on 24 well plates, 0.5 μCi of [3H]thymidine/30 μl of RPMI-1640 was added 
to each well and incubated for 4 hours at 37 °C, 5 % CO2. After 4 hours, medium was 
removed and cells were washed with ice-cold PBS. Thereafter 300 μl/well of 10 % (w/v) 
trichloroacetic acid (TCA) was added, and the lysates were incubated at 4 °C. After 30 min, 
precipitates were washed with 10 % TCA, air dried for 40 minutes and resuspended in 300 μl 
of 1 M KOH. [3H]thymidine incorporated into DNA was assessed in aliquots of 250 μl by 
liquid scintillation counting. 
 
Islet perifusion. Perifusions were performed essentially as described by [27]. In brief, groups 
of 100 islets were cultured for 12 hours followed by transfection with adenoviral constructs. 
Islet mass was kept constant between the groups. After further culture for 72 hours, islets 
were loaded onto nylon filters (Brandel Suprafusion) and perifused in a Krebs-Ringer 
bicarbonate (KRB) buffer at a flow rate of 0.4 ml/minute for 90 minutes in 2.8 mM D-glucose 
to establish basal insulin secretory rates. Thereafter, islets were perifused with 20 mM D-
glucose for 60 minutes followed by 2.8 mM D-glucose for 60 minutes. Perifusate solutions 
were prewarmed to 37°C. Fractions of 1 ml were collected and insulin content was 
determined by radioimmunoassay (RIA, CIS Bio International, Gif-Sur-Yvette, France). 
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Expression of transgenes was confirmed by Western blotting. 1st phase insulin secretion was 
defined as the four-minute time interval around the highest insulin value after D-glucose was 
changed from 2.8 to 20 mM. Basal insulin secretion was calculated from the four insulin 
values prior to the 1st phase. 2nd phase was defined as 15 insulin values following the 1st 
phase. 
 
 
Statistical Analysis. Data are expressed as means +/- standard error (SE) and were analysed 
by Student's t-test for paired (where indicated) or unpaired comparison. A p value of <0.05 
was considered significant. 
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Results 
 
Transfection with adenovirus and overexpression of IRS2 in rat pancreatic islets cultured in 
suspension and on ECM plates. We used an adenovirus-based vector system with the 
cytomegalovirus promoter to drive high-level expression of IRS2 in isolated islets. In order to 
assess the potency of the system, we used a polyclonal anti-IRS2 antibody to determine levels 
of IRS2 by Western blot analysis in rat islets at different time points after transfection with 
either GFP encoding control virus or with virus that encoded IRS2 (Adv-GFP or Adv-IRS2, 
respectively). The result is shown in Fig. 1A. Six hours after transfection, protein extracts 
from Adv-IRS2 treated islets contained more IRS2 than Adv-GFP treated controls. The 
amount of IRS2 protein increased throughout the course of the experiment with the strongest 
signal being present at 72 hours. Since immunoblot analysis of IRS2 expression does not 
reveal the distribution of expressing cells in situ, we used the same antibody to compare IRS2 
expression in fixed rat islets after four days with or without transfection with Adv-IRS2. As 
shown in Fig. 1B, IRS2 was weakly expressed in control islets while islets that had been 
transfected with Adv-IRS2 showed strong expression in all cells.  
 
 
Overexpression of IRS2 in isolated islets induces proliferation of β-cells. To address the 
question if IRS2 is sufficient to induce proliferation in pancreatic islets we used an antibody 
against the Ki-67 nuclear antigen in combination with anti-insulin staining to determine the 
number of proliferating β-cells in isolated islets without or after transfection with Adv-IRS2 or 
Adv-GFP. Since human β-cells showed a very low proliferation rate in our isolations we were 
unable to obtain statistically significant results with the limited number of available human 
donors. Therefore, we used rat islets for our experiments. As shown in Fig. 2, transfection of 
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rat islets with Adv-IRS2 increased the number of Ki-67-positive β-cells on average 9-fold over 
untransfected controls (9.5±1.3 vs. 1±0.3, p<0.05) after three days. After five days, the 
increase was about 8 fold (6.23±3.1 vs. 0.7±0.1, ). Treatment with Adv-GFP did not 
significantly increase β-cell proliferation as compared to untransfected controls at three 
(1.2±0.2 vs. 1±0.3, n.s.) or five days (1.52±0.31 vs. 0.7±0.1, n.s.) post transfection, 
respectively. Next, we wanted to test whether the effect was specific for IRS2 or if 
overexpression of two other major insulin receptor substrates, Shc and IRS1, also induces β-
cell proliferation. To this end, we overexpressed IRS1, IRS2, Shc or GFP in rat islets and 
determined the Ki-67 labelling index. Again, IRS2 stimulated proliferation of β-cells around 
7-fold. As shown in Fig. 3, overexpression of IRS1, Shc and GFP also had some proliferative 
effect as compared to untransfected controls (0.69±0.18). However, Shc (2.4±0.3) and IRS1 
(2.7±0.4) were not significantly more potent than GFP (1.4±0.4).  
 
 
Down-regulation of IRS2 in INS-1 cells decreases proliferation rate. To test if 
downregulation of Irs2 attenuates proliferation, INS-1 cells were transfected with antisense 
RNA to inhibit IRS2 expression and [3H]thymidine incorporation was measured. A 21 nt 
antisense RNA specific for Irs2 reduced IRS2 expression five days after transfection by 70 % 
(Fig. 4B, lane 4). The complementary oligonucleotide corresponding to the sense strand or 
transfection without RNA were used as controls and had no effect on IRS2 expression (Fig. 
4B, lanes 2 and 1, respectively). Thymidine incorporation following transfection with the 
antisense oligonucleotides was decreased 2-fold as compared to untransfected cells or to cells 
after transfection with sense oligonucleotide (Fig. 4A). 
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IRS2 overexpression protects human β-cells from D-glucose-induced apoptosis. As 
demonstrated earlier [7,8] chronically elevated glucose concentrations are toxic for human 
islets leading to reduced β-cell proliferation and increased β-cell apoptosis. We thus wanted 
to assess, if overexpression of IRS2 in human islets can counteract this glucotoxicity. Isolated 
human islets were cultured on ECM dishes in 5.5 mM D-glucose and transfected either with 
Adv-IRS2, Adv-IRS1 or Adv-GFP or left untreated and were thereafter cultured in 33.3 mM or 
5.5 mM D-glucose respectively, for 4 days. The numbers of apoptotic β-cells were 
determined by the TUNEL assay and the results are presented as mean percentage of control 
(at 5.5 mM D-glucose with the respective transfection) ±SE to correct for variations in 
absolute numbers between experiments. As shown in Fig. 5, culturing the islets in 33.3 mM 
D-glucose increased the mean number of TUNEL-positive β-cells per islet 3-fold (2.6±0.3 vs. 
0.9±0.3, p<0.05). High D-glucose treatment in combination with overexpression of IRS2 was 
beneficial for islets and the number of apoptotic cells was lower compared to islets also 
overexpressing IRS2 but cultured in 5.5 mM D-glucose (0.12±0.1 vs. 0.35±0.1, p<0.05). 
Overexpression of IRS1 combined with 33.3 mM D-glucose incubation did not significantly 
decrease TUNEL-positive β-cells (0.67±0.1 vs. 0.45±0.2), nor did GFP (1.1±0.5 vs. 0.6±0.4). 
The number of necrotic versus apoptotic cells was determined by annexin-V/propidium iodide 
staining after culturing in high or low D-glucose. The number of necrotic cells remained 
constant independent of viral infection and changes in ambient glucose concentrations (not 
shown). However, annexin-V-positive β-cells were more frequent in untransfected (5.8±0.5), 
Adv (5±0.8, empty vector control) and Adv-IRS1 transfected (5.2±0.9) islets than in Adv-IRS2 
transfected (1.2±0.2) islets after culture in 33.3 mM D-glucose (Fig. 5B). At 5.5 mM D-
glucose the number of annexin-V-positive β-cells per islet was 1.4±0.5 for untransfected, 
3.2±0.5 for Adv, 3.2±0.8 for Adv-IRS1 and 2.4±0.4 for islets transfected with Adv-IRS2. 
Consistent with our previous experiments, islets cultured in 33.3 mM D-glucose and 
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overexpressing IRS2 showed fewer apoptotic β-cells than islets that overexpressed IRS2 but 
had been cultured in the presence of 5.5 mM D-glucose. In contrast, after transfection with 
Adv-IRS1, Adv (empty vector) or without virus apoptotic cells were more frequent in islets 
cultured in 33.3 mM D-glucose than in islets that had been cultured in 5.5 mM D-glucose. 
This shows that overexpression of IRS2 protects against D-glucose-induced apoptosis in 
human islets. 
 
 
IRS2 does not protect rat β-cells against free fatty acid-induced apoptosis. In a next series of 
experiments we wanted to investigate whether overexpression of IRS2 could also protect β-
cells from free fatty acid-induced apoptosis. Isolated rat islets were incubated for 4 days in the 
presence or absence of 0.5 mM palmitic acid and apoptotic cells were detected using the 
TUNEL assay. As shown in Fig. 6, exposure to palmitic acid increased the number of 
apoptotic β-cells as compared to islets cultured in 11.1 mM D-glucose alone (1.85±0.85 vs. 
0.13±0.08). Neither overexpression of IRS2 (1.60±0.72 vs. 0.19±0.08) nor GFP (1.39±0.66 
vs. 0.26±0.11) prevented the apoptotic effect of palmitic acid. Overexpression of IRS2 did 
also not suppress the increase in the number of TUNEL-positive β-cells in the presence of 
palmitic acid at 0.1 mM and 0.3 mM, respectively (not shown). 
 
Overexpression of IRS2 in isolated rat islets increases insulin secretion. The influence of 
high-level expression of IRS2 or IRS1 on insulin secretion was determined in perifusion 
experiments (Fig. 7A and B). As control, islets were transfected with Adv or were left 
untreated. Perifusion after a total culture period of 94 hours showed biphasic insulin secretion. 
Islets overexpressing IRS2 secreted significantly more total insulin (1.58±0.14 fold, p<0.05) 
as compared to treatment with Adv (Fig. 7B). Their basal and second phase insulin secretions 
were increased 2.16±0.45 (p=0.074) and 1.75±0.18 fold (p<0.05), respectively. Islets 
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transfected with Adv-IRS1 showed insulin secretion levels similar to transfection with Adv. 
Transfection with Adv or Adv-IRS1 reduced basal (0.65±0.05, p<0.05 and 0.82±0.16, ns) and 
second phase insulin secretion (0.74±0.06, p<0.05 and 0.78±0.12, ns) relative to untransfected 
islets, while islets transfected with Adv-IRS2 displayed higher basal (1.54±0.12, ns) and 
second phase (1.31±0.13, p<0.05) insulin secretion as compared to no transfection. 
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Discussion 
 
Our findings in human and rat pancreatic islets provide evidence that IRS2 is pivotal for 
the maintenance of β-cell mass both by inducing proliferation of β-cells and protecting them 
from glucotoxicity. The role of IRS2 in β-cell proliferation has been studied previously, and it 
was found that IGF-I increases proliferation in the insulinoma-derived cell line INS-1 via 
IRS2 [28]. On the other hand, mice deficient for IRS2 show mild β-cell deficiency already at 
birth. Such mice are unable to expand β-cell mass to compensate for insulin resistance and 
develop diabetes [16]. This phenotype implies a requirement for IRS2 in the regulation of β-
cell mass during embryogenesis. A later requirement for IRS2 in the adult can not be deduced 
from these animals because of possible secondary effects of the systemic knock-out of the 
Irs2 gene. Furthermore, because tissue-specific knock-out mice are not yet available the 
question about autonomy remains unanswered as well. With our study we present evidence 
for a cell autonomous and instructive (and not only permissive) role of IRS2 in the control of 
β-cell mass (Fig. 2). Nevertheless, final proof for autonomy requires a transgene that directs 
IRS2 expression under a constitutive, β-cell-specific promoter. Therefore, it remains possible 
that proliferation of β-cells was dependent on expression of IRS2 in other islet cell types. We 
believe, however, that chances are low for such inductive events because insulin staining 
indicates that islets from our preparations consist to more than 90 % of β-cells (Fig. 2). With 
respect to the question of when IRS2 function is required in β-cells our results support the 
view that IRS2 is continuously required for proliferation. When we repressed Irs2 in INS-1 
cells by antisense RNA oligonucleotides we found a 2-fold reduction in proliferation as 
determined by thymidine incorporation assays (Fig. 4). On the other hand, high-level 
expression enhanced β-cell proliferation in differentiated islets in vitro and therefore IRS2 
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was capable to bring β-cells into the cell cycle at this stage. It is important to note that, 
although IRS2 was overexpressed in all β-cells after transfection of islets, not all β-cells 
entered the cell cycle (Fig. 1B). This might be due to differences in expression levels or a 
superimposed mechanism must exist that limits the number of β-cells that can proliferate per 
islet and IRS2 is not able to override this control in our experimental system.  
Chronically elevated D-glucose concentrations have been shown to induce β-cell 
apoptosis in human islets while palmitate induces β-cell apoptosis in rats and humans. Two 
different pathways are known to be involved: D-glucose induces apoptosis through the Fas 
pathway [8,29] leading to activation of caspase-8. Palmitic acid activates the mitochondrial 
pathway and involves caspase-9 [9]. Overexpression of IRS2 in human or rat islets protected 
β-cells from D-glucose- but not from palmitic acid-induced apoptosis (Fig. 5 and 6). The 
finding in human islets indicates that there is cross-talk between IRS2-dependent signalling 
and the Fas pathway. Maedler et al. [30] have shown that sufficiently high levels of FLIP(L) 
(long isoform of FLIP generated by alternative splicing) in β-cells are required to protect 
against the toxic effect of chronic hyperglycaemia and to attenuate Fas signalling. It is 
therefore tempting to speculate that IRS2 is a positive regulator of FLIP. We are currently 
testing this possibility by studying the expression of FLIP in human islets that overexpress 
IRS2. It was shown that activation of Akt/PKB plays an important role in preventing free fatty 
acid-induced apoptosis in INS-1 cells [31]. However, overexpression of IRS2 in isolated rat 
islets did not protect β-cells from palmitic acid-induced apoptosis (Fig. 6), although Akt/PKB 
can be a downstream target of IRS2 signalling. Therefore, transfection of isolated rat islets 
with Adv-IRS2 in the presence of 0.5 mM palmitic acid might not lead to activation of 
Akt/PKB. Unfortunately, we were not able to detect any form of Akt/PKB in our lysates so 
far (not shown).  
 19
S. Mohanty et al. Ectopic expression of IRS2 in isolated islets 
It is well established that short term exposure of rat and human islets to D-glucose causes 
proliferation of β-cells [32,8,33]. In contrast, human islets cultured in vitro for extended 
periods of time in the presence of high D-glucose display enhanced β-cell apoptosis and a 
reduced proliferation rate [7,29]. By overexpressing IRS2 in human islets we were able to 
completely block the pro-apoptotic effect of chronic high D-glucose on human β-cells. 
Moreover, when we cultured human islets for 3 days with 33.3 mM D-glucose and 
simultaneously overexpressed IRS2, fewer apoptotic β-cells were found compared to islets 
that overexpressed IRS2 in the presence of 5.5 mM D-glucose (Fig. 5). If the same holds true 
in vivo this result underlines the central role of IRS2 in human β-cells during the development 
of type 2 diabetes. High levels of IRS2 in the face of insulin resistance and hyperglycemia 
would be beneficial and prevent β-cell apoptosis. Along this line, it might be loss of IRS2 
expression in β-cells under persisting hyperglycemia that leads to loss of β-cell mass and 
development of diabetes. Analysis of IRS2 levels in β-cells under normo- and hyperglycemic 
conditions is needed to test this hypothesis. A recent study does indeed show a link between 
D-glucose and IRS2 levels in β-cells. [34] a finding which was confirmed by our own 
unpublished observations. In this context, our findings suggest that upregulation of IRS2 by 
D-glucose is sufficient to induce proliferation and to suppress D-glucose-induced apoptosis of 
β-cells. Data by Hennige et al. [20] support this view and confirm the importance of IRS2 in 
β-cells in vivo.  
Overexpression of IRS2 but not IRS1 increased basal and D-glucose-induced insulin 
secretion in isolated rat islets after a culture period of 94 hours. However, IRS2 was not 
effective when we used freshly isolated islets which had been transfected for six hours (data 
not shown) indicating that the underlying mechanism does not act immediately. An increase 
in basal insulin secretion could be caused by an increased sensitivity of β-cells to D-glucose. 
It was shown that β-cells of transgenic mice expressing higher levels of IRS2 under the 
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control of the rat insulin promoter contained three times more Glut2 than controls [20]. Such 
an IRS2-induced increase in Glut2 is expected to require time because it probably involves 
transcriptional control by pdx1 [35]. As a consequence, IRS2 could indeed increase the 
sensitivity of β-cells to D-glucose resulting in elevated basal insulin concentrations. Such a 
basal increase can probably not be detected in vivo because the concentration of D-glucose in 
circulation changes in response to the insulin concentration. However, an increase in the 
sensitivity of β-cells to D-glucose is expected to improve islet performance in vivo [20].  
In conclusion, we provide evidence for an autonomous role of IRS2 in β-cells. High 
levels of IRS2 stimulate β-cell proliferation, protect them from D-glucose-induced apoptosis 
and improve insulin secretion. On the other hand, repression of IRS2 in INS-1 cells 
downregulates proliferation. IRS2-mediated signalling within β-cells could therefore maintain 
adequate functional β-cell mass independent of contributions by other tissues and prevent the 
onset of diabetes. 
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Figure Legends 
 
Fig. 1 CMV-driven expression of IRS2 in rat islets cultured in suspension. (A) Rat islets in 
suspension were transfected with Adv-IRS2 or Adv-GFP as control (c). After the indicated 
periods of time, islets were handpicked and lysed in SDS buffer. Lysates were analysed by 
Western blotting and IRS2 expression was detected with a polyclonal antibody against IRS2. 
(B) Flattened rat islets on ECM plates were transfected with Adv-IRS2 or Adv-GFP as control 
(c) and cultured for 72 hours. One half of the islets was immunostained in situ for IRS2 to 
determine the distribution of expressing cells and to compare levels of endogenous (B) and 
overexpressed IRS2 (D). Pictures A and C show the same islets as under B and D but 
visualised in the light-field. The second half of the islets was scraped off the plates, lysed and 
IRS2 expression was detected by Western blotting. 
 
 
Fig. 2 Overexpression of IRS2 in rat islets increases proliferation of β-cells. Rat islets on 
ECM plates were transfected with Adv-GFP or Adv-IRS2 and incubated for 3 or 5 days. 
Proliferating β-cells were detected with a monoclonal antibody against Ki-67 and co-staining 
for insulin. The total number of Ki-67 positive β-cells was counted and normalised to control 
incubation without transfection. Results are shown as mean ± SE of five independent 
experiments. For each experiment between 10-20 islets were counted per dish in triplicate for 
each condition. * P<0.05 relative to islets transfected with Adv-GFP. A representative islet 
stained for Ki-67 and co-stained for insulin is shown. Arrows mark cells positive for Ki-67. 
 
 
Fig. 3 Proliferation of rat β-cells after overexpression of IRS2, IRS1, Shc and GFP. Rat islets 
on ECM plates were transfected with Adv-GFP, Adv-Shc, Adv-IRS1 or Adv-IRS2 and β-cell 
proliferation was detected after 3 days. Number of Ki-67 positive β-cells/islet are shown as 
mean ±SE (n=3). 10-20 islets were counted per dish in triplicate for each condition. * P<0.05 
relative to islets without transfection and to islets transfected with Adv-IRS1.  
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Fig. 4 Downregulation of IRS2 in INS-1 cells inhibits proliferation. INS-1 cells were grown 
to 70% confluence and transfected with the indicated RNA oligonucleotides. After 5 days, 
proliferation was assessed by measuring [3H]thymidine incorporation. (A) Results are shown 
as mean ± SE of four independent experiments. * P<0.05 relative to cells transfected with 
sense RNA. Control represents cells treated with Oligofectamine alone. (B) Expression of 
IRS2 after transfection was assessed by Western blotting. β-actin was used as a loading 
control. Lane 1: Oligofectamine alone, Lane 2: inverted double stranded RNA (control ), Lane 
3: sense RNA (control ), Lane 4: antisense RNA, Lane 5: double stranded RNA (dsRNA). In 
this experiment dsRNA was also used to repress IRS2. Note that the antisense RNA 
oligonucleotide represses IRS2 expression more efficiently than the dsRNA. Therefore, we 
used only the anti sense RNA oligonucleotide in four experiments to downregulate IRS2 and 
measure proliferation. 
 
 
Fig. 5 Overexpression of IRS2 in human islets protects β-cells from D-glucose-induced 
apoptosis. Human islets on ECM plates were transfected with Adv-GFP, Adv-IRS1 or Adv-
IRS2 and cultured for 4 days in medium containing 5.5 mM or 33.3 mM D-glucose. (A) 
Apoptotic β-cells were detected by TUNEL and co-staining for insulin. A representative islet 
is shown and the arrow marks a β-cell positive for TUNEL. Results of three independent 
experiments (each condition in triplicate per experiment, 10-20 islets were counted per dish) 
are shown as mean ± SE in percent of control at 5.5 mM D-glucose and transfection with the 
respective viral construct. * P<0.05 relative to islets transfected with Adv-IRS2 at 5.5 mM D-
glucose. (B) Single experiment performed as under (A) but with staining for annexin-V 
instead of TUNEL. Adv-GFP was replaced by an adenoviral vector that did not express a 
transgene (empty vector).  
 
 
Fig. 6 IRS2 does not protect rat β-cells from palmitic acid-induced apoptosis. Rat islets on 
ECM plates were transfected with Adv-GFP and Adv-IRS2 and cultured in the presence or 
absence of 0.5 mM palmitic acid. After 4 days, TUNEL assay was performed and the average 
number of TUNEL positive β-cells/islet was determined. Data are presented as mean ±SE 
(n=4). 10-20 islets were counted per dish in triplicate for each condition in the four 
experiments. 
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Fig. 7 IRS2 increases insulin secretion in isolated rat islets. Rat islets were treated and 
perifused as described under materials and methods. (A) Mean curves calculated from four 
independent perifusions. Data points are presented ±SE. (B) Insulin secretion relative to islets 
transfected with Adv. Area under the curve (AUC) was calculated in each of the four 
experiments for basal, 1st phase, 2nd phase and total insulin secretion. The ratio was formed 
between AUC of each condition and the respective values for transfection with Adv. Bars 
represent mean ratios ±SE. * p<0.05 relative to islets transfected with Adv (Student's t-test for 
paired comparison). 
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